ECDC risk assessment: 2009 influenza A(H1N1) pandemic (Update 17 December 2009)
This update of the ECDC pandemic risk assessment for Europe is based on data and analyses available in early December 2009. It draws on the experience in European countries, North America and the Southern Hemisphere’s temperate countries, which have already passed through a winter with the new virus. This description deals with the infection and the disease. Specifically, it does not include comments on the pharmaceutical countermeasures, nor their likely effectiveness and safety. These are dealt with separately in dedicated ECDC documents.
Rapid risk assessment: Dengue outbreak in Réunion, France, and associated risk of autochthonous outbreak in the EU/EEA
18 Jun 2019 - This update of the risk assessment ‘Dengue outbreak in Réunion, France’ published on 5 July 2018, has been triggered by the significant size of the outbreak and its expected duration, which is anticipated to overlap with high vector activity in the southern EU.
Rapid risk assessment: Chlamydia trachomatis false-negative test results by Aptima Combo 2 CT/NG assay (Hologic) in the EU/EEA, 2019
17 Jun 2019 - In April 2019, Finland reported false-negative or equivocal results in patients tested for Chlamydia trachomatis (CT) using Aptima Combo 2 Assay (Hologic) (AC2).
Multi-country outbreak of Listeria monocytogenes clonal complex 8 infections linked to consumption of cold-smoked fish products
4 Jun 2019 - This joint ECDC-EFSA rapid outbreak assessment provides an assessment of the cross-border public health risk related to L. monocytogenes infections linked to the consumption of cold-smoked fish products, possibly originating from a single food processing company.